X T L Biopharmaceuticals reported $9.3M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 6M 1000K Jun/2026
Bioline Rx USD 177M 138M Nov/2026
Teva Pharmaceutical Industries USD 152.12B 105.39B Nov/2026
X T L Biopharmaceuticals USD 22M 8M Dec/2024